Variability Analysis as a Predictor of Liberation From Mechanical Ventilation

June 8, 2010 updated by: The Cleveland Clinic

Variability Analysis as a Predictor of Liberation From Mechanical Ventilation in Patients Admitted to the Respiratory Special Care Unit (ReSCU)

The purpose of this study is to evaluate if the variability of biological signals, such as heart rate and temperature, can predict weaning from mechanical ventilation in patients with failure to wean.

Study Overview

Detailed Description

Failure to wean is one of the most feared complications of mechanical ventilation. Prolonged mechanical ventilation occurs in 5-20% of all patients requiring MV in an intensive care unit. The published experience in the Cleveland Clinic in-hospital-weaning unit (ReSCU, Respiratory Special Care Unit) on long-term mechanical ventilation (>14 days) is that on average, 60% of the patients achieve complete ventilator independence.

The identification of factors that predict liberation from mechanical ventilation should improve outcomes and allocation of resources. Several attempts have been done to develop models to identify patients who will wean from prolonged MV; most rely on multiple measurements and their predictive ability is uncertain. Given the complexity of medical problems and the heterogeneity of the patients with prolonged MV, it is not unexpected that in order to achieve a good prediction, multiple variables are needed to encompass the whole population and relevant factors associated with the failure to wean.

Heart rate variability (HRV) is obtained from the measurement of the interval between successive heart beats; its analysis has been used extensively in cardiovascular disease. HRV is interpreted as a manifestation of the neurohumoral and autonomic system influence over the heart. Some researchers think that HRV relates to overall variability and is a manifestation of health in a complex biological system. Interpretation apart, multiple studies have demonstrated that the loss of variability reflects a poor prognosis overall. This phenomenon is seen not only in the heart, but also in breathing patterns, blood pressure, leukocyte count, electroencephalogram, gait, and recently in temperature. Limitations in interpretation and difficulty in acquisition (ventilator influence, respiratory rate influence, arrhythmias, medication) make HRV less practical in the mechanically ventilated population.

Surface temperature is not usually measured in clinical practice; it reflects skin thermoregulatory properties (where the autonomic system has a fundamental role). Recently, a novel marker to describe biological variability in body temperature has been studied. The temperature curve complexity (TCC) was used to predict mortality in critically ill patients. Its performance was comparable to that of scores like APACHE and SOFA, this has been described with HRV, hence suggesting a relation between TCC and HRV. Although no prior study has related TCC or HRV alone or to prolonged mechanical ventilation outcomes, there is reason to suspect that variability is decreased in ventilator-dependent patients.

In summary, the analysis of HRV and TCC has provided prognostic information in critically ill patients. A relation between HRV and TCC is expected but has not been described. Given the multiple influences of MV on HRV, TCC may be a better indicator of of variability in patients on MV. Our primary hypothesis is that the analysis of HRV and TCC will predict failure to wean from prolonged MV. Our secondary aims are: to identify the relationship between HRV and TCC, to describe the TCC in patients with prolonged MV, and to describe the changes in HRV and TCC in patients with successful and failed weaning.

This is an observational study in which measurements of HRV and TCC will be done in patients admitted to the ReSCU and compared to the ability to wean from mechanical ventilation.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Respiratory Special Care Unit, Cleveland Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients that were admitted to the Respiratory Special Care Unit (ReSCU)

Description

Inclusion Criteria:

  • All patients being admitted to the Respiratory Special Care Unit (ReSCU) will be considered for this study.

Exclusion Criteria:

  • Current pregnancy
  • Age < 18 years old
  • No baseline temperature measurements
  • Second or greater admission to ReSCU
  • Patient refusal to participate in the study
  • Allergy to adhesive tape
  • Pacemaker or implanted electronic devices on the thorax

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eduardo Mireles-Cabodevila, MD, The Cleveland Clinic
  • Study Director: James K Stoller, MD, The Cleveland Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Study Completion (ACTUAL)

March 1, 2008

Study Registration Dates

First Submitted

June 8, 2010

First Submitted That Met QC Criteria

June 8, 2010

First Posted (ESTIMATE)

June 9, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

June 9, 2010

Last Update Submitted That Met QC Criteria

June 8, 2010

Last Verified

June 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autonomic Nervous System Diseases

Subscribe